Healthcare Roundup – Lannett enters new insulin glargine deal with HEC, Merck’s Keytruda lands another approval in China Nov 26, 2019 Life Science
Healthcare Roundup –JanOne acquires license, Teva in talks with DoJ, Seattle Genetics earns drug approval Nov 25, 2019 Life Science
Verseau Therapeutics Launches with $50 Million to Reprogram Immune Cells to Treat Cancer Oct 22, 2019 Life Science
Chenguang Biotech to Build USD30 Million Tomato Processing Plant in California Oct 9, 2019 Life Science